Protein expression analysis of a high-demeclocycline producing strain of Streptomyces aureofaciens and the roles of CtcH and CtcJ in demeclocycline biosynthesis

Abstract

Background

Streptomyces aureofaciens strain A6-9, obtained with traditional mutagenesis, produces elevated levels of 6-DCT. The increased formation of 6-DCT may be attributable to the changes in the expression of some proteins in the 6-DCT biosynthetic pathway. For this reason, we explored the differences in protein expression between A6-9 and wild-type (WT) strains of Streptomyces aureofaciens, and based on the differences (CtcH and CtcJ were overexpressed in A6-9), investigated the roles of CtcH and CtcJ in biosynthesis.

Results

Two-dimensional gel electrophoresis and a Mascot search indicated that some enzymes (including CtcH and CtcJ) involved in the primary and secondary metabolism were more strongly expressed in the high-6-DCT-yielding strain A6-9 than in the WT strain DT1. To examine the roles of CtcH and CtcJ in 6-DCT biosynthesis, ctcH-deleted, ctcJ-deleted, ctcH-overexpressing, and ctcJ-overexpressing mutants and a mutant overexpressing both ctcH and ctcJ were constructed. Compared with WT, 6-DCT production was 50 and 37 % higher in the ctcH-overexpressing and ctcJ-overexpressing strains, respectively, and increased by 60 % in the ctcH–ctcJ-overexpressing strain. The ctcH-deleted and ctcJ-deleted strains produced almost no 6-DCT. Analysis of the metabolic flux distribution indicated that ctcH encodes a hydroxyacyl-CoA dehydrogenase and ctcJ encodes a monooxygenase that are essential for 6-DCT biosynthesis.

Conclusion

Protein expression differs between high-6-DCT-yielding and WT strains, and the enzymes increased in the high-6-DCT-yielding strain explain the increased 6-DCT production. ctcH encodes a hydroxyacyl-CoA dehydrogenase and ctcJ encodes a monooxygenase that are essential for 6-DCT biosynthesis.

Keywords

Biosynthesis / Demeclocycline / Streptomyces aureofaciens / Two-dimensional gel electrophoresis

References

[1] Al-Shamma KJ, Karim KH, Al-Genno GM. Biological effects of inhaled welding fumes from flux-coated electrodes (OK 46.00). Dev Toxicol Environ Sci, 1983, 11: 487-490.

[2] Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature, 2002, 417: 141-147.

[3] Black PN, DiRusso CC. Molecular and biochemical analyses of fatty acid transport, metabolism, and gene regulation in Escherichia coli. Biochim Biophys Acta, 1994, 1210: 123-145.

[4] DiRusso CC, Nystrom T. The fats of Escherichia coli during infancy and old age: regulation by global regulators, alarmones and lipid intermediates. Mol Microbiol, 1998, 27: 1-8.

[5] Du D, Zhu Y, Wei J, Tian Y, Niu G. Improvement of gougerotin and nikkomycin production by engineering their biosynthetic gene clusters. Appl Microbiol Biotechnol, 2013, 97: 6383-6396.

[6] Faust B, Hoffmeister D, Weitnauer G, Westrich L, Haag S. Two new tailoring enzymes, a glycosyltransferase and an oxygenase, involved in biosynthesis of the angucycline antibiotic urdamycin A in Streptomyces fradiae Tu2717. Microbiology, 2000, 146: 147-154.

[7] Fujita Y, Matsuoka H, Hirooka K. Regulation of fatty acid metabolism in bacteria. Mol Microbiol, 2007, 66: 829-839.

[8] Gaisser S, Lill R, Staunton J, Mendez C, Salas J. Parallel pathways for oxidation of 14-membered polyketide macrolactones in Saccharopolyspora erythraea. Mol Microbiol, 2002, 44: 771-781.

[9] Helmel M, Posch A, Herwig C, Allmaier G, Marchetti-Deschmann M. Proteome profiling illustrated by a large-scale fed-batch fermentation of Penicillium chrysogenum. EuPA, 2014, 4: 113-120.

[10] Hensel M, Deckers-Hebestreit G, Altendorf K. Purification and characterization of the F1 portion of the ATP synthase (F1Fo) of Streptomyces lividans. Eur J Biochem, 1991, 202: 1313-1319.

[11] Jan K, Renata N, Eric M, Lubomira F. Intriguing properties of the angucyclineantibiotic auricin and complex regulation of its biosynthesis. Appl Microbiol Biotechnol, 2014, 98: 45-60.

[12] Jian J, Zhang SQ, Shi ZY, Wang W, Chen GQ. Production of polyhydroxyalkanoates by Escherichia coli mutants with defected mixed acid fermentation pathways. Appl Microbiol Biotechnol, 2010, 87: 2247-2256.

[13] Kunau WH, Dommes V, Schulz H. Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res, 1995, 34: 267-342.

[14] Li XM, Novotna J, Vohradsky J, Weiser J. Major proteins related to chlortetracycline biosynthesis in a Streptomyces aureofaciens production strain studied by quantitative proteomics. Appl Microbiol Biotechnol, 2001, 57: 717-724.

[15] Liu F, Xu D, Zhang Y, Zhu Y, Ye J. Identification of BagI as a positive transcriptional regulator of bagremycin biosynthesis in engineered Streptomyces sp. Tu 4128. Microbiol Res, 2015, 173: 18-24.

[16] Lu YJ, Rock CO. Transcriptional regulation of fatty acid biosynthesis in Streptococcus pneumoniae. Mol Microbiol, 2006, 59: 551-566.

[17] Malla S, Niraula NP, Liou K, Sohng JK. Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement. Microbiol Res, 2010, 165: 259-267.

[18] Mikulik K, Jiranova K, Janda I, Weiser J. Susceptibility of ribosomes of the tetracycline-producing strain of Streptomyces aureofaciens to tetracyclines. FEBS Lett, 1983, 152: 125-130.

[19] Nakano T, Miyake K, Ikeda M, Mizukami T, Katsumata R. Mechanism of the incidental production of a melanin-like pigment during 6-demethylchlortetracycline production in Streptomyces aureofaciens. Appl Environ Microbiol, 2000, 66: 1400-1404.

[20] Pang AP, Du L, Lin CY, Qiao J, Zhao GR. Co-overexpression of lmbW and metK led to increased lincomycin A production and decreased by product lincomycin B content in an industrial strain of Streptomyces lincolnensis. J Appl Microbiol, 2015, 119: 1064-1074.

[21] Pramanik A, Pawar S, Antonian E, Schulz H. Five different enzymatic activities are associated with the multienzyme complex of fatty acid oxidation from Escherichia coli. J Bacteriol, 1979, 137: 469-473.

[22] Rock CO, Cronan JE. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim Biophys Acta, 1996, 1302: 1-16.

[23] Schujman GE, Paoletti L, Grossman AD, Mendoza D. FapR, a bacterial transcription factor involved in global regulation of membrane lipid biosynthesis. Dev Cell, 2003, 4: 663-672.

[24] Taguchi T, Okamoto S, Hasegawa K, Ichinose K. Epoxyquinone formation catalyzed by a two-component flavin-dependent monooxygenase involved in biosynthesis of the antibiotic actinorhodin. ChemBioChem, 2011, 12: 2767-2773.

[25] Volodina E, Steinbuchel A. (S)-3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA hydratase (FadB’) from fatty acid degradation operon of Ralstonia eutropha H16. AMB Express, 2014, 4: 69.

[26] Yuan T, Yin C, Zhu C, Zhu B, Hu Y. Improvement of antibiotic productivity by knock-out of dauW in Streptomyces coeruleobidus. Microbiol Res, 2011, 166: 539-547.

[27] Zhang Y, Li Y, Du C, Liu M, Cao Z. Inactivation of aldehyde dehydrogenase: a key factor for engineering 1,3-propanediol production by Klebsiella pneumoniae. Metab Eng, 2006, 8: 578-586.

[28] Zhang X, Fen M, Shi X, Bai L, Zhou P. Overexpression of yeast S-adenosylmethionine synthetase metK in Streptomyces actuosus leads to increased production of nosiheptide. Appl Microbiol Biotechnol, 2008, 78: 991-995.

[29] Zhu J, Snow DD, Cassada DA, Monson SJ, Spalding RF. Analysis of oxytetracycline, tetracycline, and chlortetracycline in water using solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A, 2001, 928: 177-186.

[30] Zhu YX, Xu DK, Liao SY, Ye J, Zhang HZ. Cloning and characterization of bagB and bagC, two co-transcribed genes involved in bagremycin biosynthesis in Streptomyces sp Tu 4128. Ann Microbiol, 2013, 63: 167-172.

[31] Zhuo Y, Zhang W, Chen D, Gao H, Tao J. Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis. Proc Natl Acad Sci USA, 2010, 107: 11250-11254.

Funding

Topfond Pharmaceutical Co., Ltd, Henan, China